Insider: Gallagher Carol Giltner Director - Atara Biotherapeutics, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 459,418 | 62,656 | 522,074 |
| Value | $6,183,766.28 | $843,349.76 | $7,027,116.04 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 11/14/2023 | AAP | 90,980 | Direct | COM | $0.31 | $28,185.60 | 459,418 |
| 11/13/2023 | AAP | 179,020 | Direct | COM | $0.22 | $40,028.87 | 368,438 |
| 11/07/2018 | DDS | 21,374 | Direct | COM | $36.38 | $777,586.12 | 88,818 |
| 06/18/2018 | DDS | 400 | Direct | COM | $45.29 | $18,116.00 | 110,192 |
| 06/18/2018 | DDS | 2,100 | Direct | COM | $44.68 | $93,828.00 | 110,592 |
| 05/16/2018 | DDS | 273 | Direct | COM | $46.06 | $12,574.38 | 111,192 |
| 11/16/2017 | DDS | 1,184 | Direct | COM | $14.20 | $16,812.80 | 109,738 |
| 06/09/2017 | DDS | 1,000 | Direct | COM | $13.15 | $13,150.00 | 107,374 |
| 05/16/2017 | DDS | 1,184 | Direct | COM | $15.25 | $18,056.00 | 103,374 |
| 02/16/2017 | DDS | 1,183 | Direct | COM | $16.10 | $19,046.30 | 102,192 |
| 11/16/2016 | DDS | 1,184 | Direct | COM | $19.35 | $22,910.40 | 99,010 |
| 05/18/2016 | DDS | 1,184 | Direct | COM | $15.96 | $18,896.64 | 95,462 |
| 02/17/2016 | DDS | 1,183 | Direct | COM | $16.30 | $19,282.90 | 94,280 |
| 11/17/2015 | DDS | 1,184 | Direct | COM | $31.10 | $36,822.40 | 93,098 |
| 08/24/2015 | DDS | 2,736 | Direct | COM | $40.67 | $111,273.12 | 93,195 |
| 08/24/2015 | DDS | 627 | Direct | COM | $38.44 | $24,101.88 | 97,163 |
| 08/24/2015 | DDS | 1,279 | Direct | COM | $41.88 | $53,564.52 | 91,916 |
| 08/24/2015 | DDS | 1,232 | Direct | COM | $39.77 | $48,996.64 | 95,931 |
| 08/21/2015 | DDS | 448 | Direct | COM | $42.46 | $19,022.08 | 97,790 |
| 08/21/2015 | DDS | 5,426 | Direct | COM | $41.65 | $225,992.90 | 98,238 |
| 08/20/2015 | DDS | 3,274 | Direct | COM | $45.88 | $150,211.12 | 103,664 |
| 08/20/2015 | DDS | 600 | Direct | COM | $44.08 | $26,448.00 | 106,938 |
| 08/20/2015 | DDS | 2,000 | Direct | COM | $43.24 | $86,480.00 | 107,538 |
| 08/19/2015 | DDS | 1,500 | Direct | COM | $48.78 | $73,170.00 | 109,538 |
| 08/19/2015 | DDS | 4,375 | Direct | COM | $47.98 | $209,912.50 | 111,038 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research